Assembly Biosciences (ASMB) Non-Current Deffered Revenue (2017 - 2025)
Assembly Biosciences' Non-Current Deffered Revenue was $1.72 million in Q3 2025, down 94.7% from $32.51 million a year earlier and down 86.8% from the prior quarter.
Powered by 
Analysis
Assembly Biosciences (ASMB) Non-Current Deffered Revenue (2017 - 2025) Analysis & Trends
At the end of FY2024, Non-Current Deffered Revenue at Assembly Biosciences came in at $35.38 million, down 36.1% from FY2023.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of 2.9% (FY2019 to FY2024).
- In earlier years, Non-Current Deffered Revenue was $55.38 million in FY2023, $2.73 million in FY2022 (unchanged), $2.73 million in FY2021 (-69.6%) and $8.99 million in FY2020 (-70.7%).
- The Q3 2025 figure marks the lowest quarterly Non-Current Deffered Revenue in data going back to Q1 2017.
- Compared with a year earlier, Non-Current Deffered Revenue has declined for four straight quarters, with an average decline of 62.4% over the last four quarters.
- Across the past five years, year-over-year decline in Non-Current Deffered Revenue ran from 0.0% in Q3 2023 to 94.7% in Q3 2025.
- Per Business Quant data, ASMB's Non-Current Deffered Revenue in the three quarters before Q3 2025 was $13.04 million (Q2 2025), $22.76 million (Q1 2025) and $35.38 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Assembly Biosciences | 466.28 Mn | -561.34 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 13.04 Mn |
| Mar 31, 2025 | 22.76 Mn |
| Dec 31, 2024 | 35.38 Mn |
| Sep 30, 2024 | 32.51 Mn |
| Jun 30, 2024 | 38.92 Mn |
| Mar 31, 2024 | 47.74 Mn |
| Dec 31, 2023 | 55.38 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 2.73 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 2.73 Mn |
| Sep 30, 2022 | 2.73 Mn |
| Jun 30, 2022 | 2.73 Mn |
| Mar 31, 2022 | 2.73 Mn |
| Dec 31, 2021 | 2.73 Mn |
| Sep 30, 2021 | 2.73 Mn |
| Jun 30, 2021 | 8.99 Mn |
| Mar 31, 2021 | 8.99 Mn |
| Dec 31, 2020 | 8.99 Mn |
API Access
Assembly Biosciences Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ASMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ASMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ASMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();